Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. freshman Avg
|
New words:
abbreviated, abiraterone, added, adenocarcinoma, ADVENTRX, Amex, androgen, antigen, antimetabolite, antisense, Arno, Arrieta, AstraZeneca, autoimmune, axitinib, baseline, bearing, belief, benign, bonusand, brostallicin, Canadian, carboplatin, carcinoma, career, cavity, central, chest, cilengitide, Concentrate, Conclusion, crizotinib, crystal, deferral, Dendreon, depositor, doublet, driven, element, emphasize, enantiomeric, endothelin, Equilar, eribulin, Es, expansion, Fejleszto, formula, formulation, Fyn, gave, glioma, hope, hormonal, hormone, IIIB, impending, inflammatory, influence, insulin, Iressa, Journal, Kutato, left, macroeconomic, malignancy, malignant, Medivation, men, Mexico, necitumumab, neuropharmacokinetic, nontaxable, NSCLC, numerical, NYSE, Oforta, OfortaTM, OTC, outright, palifosfamide, payroll, peripheral, Pink, preceding, precluded, presence, PROACT, prostate, Provenge, PSA, Radford, regimen, reject, retrospectively, revert, score, scoring, Secondarily, Serono, shrink, shrinkage, spending, spin, stabilization, stake, supervisor, survey, tablet, Taiho, taxane, Taxotere, undergone, unextended, unwarranted, USA, vascular, vinka, viral, waiting, watchful, weak, worst, ZIOPHARM
Removed:
absence, affiliate, AG, allocating, Alzheimer, amplifying, anniversary, APB, arm, artery, billion, Biogen, BioMedica, blockage, brachial, breathe, Bunker, capacity, capsule, carry, cautionary, Celgene, cerebral, Ceregene, coenzyme, concurrent, creatine, Czech, deadly, debilitating, decision, degeneration, demonstrating, deprivation, detected, disabled, disposing, dosage, dysfunction, efficiently, Elan, encourage, endothelium, extreme, facilitate, FAS, Faust, flow, fluctuation, foot, Forest, FSP, functional, Genentech, Gregory, Guide, half, Hannon, heal, heavily, hemorrhagic, Hill, Huntington, Idec, IIa, IIb, implicated, indistinguishable, Ingelheim, interior, ischemic, Knopp, language, layer, leaking, letter, lifetime, literature, lithium, Lundbeck, marker, measuring, Michael, Mitsubishi, modifying, motor, neurodegenerative, Ono, onset, Oxford, oxygen, passed, pathway, people, permanently, Phytopharm, plc, preemptive, pressure, processed, progressive, proper, Rana, recruit, replacement, reproduced, restored, retained, rilutek, RXII, SA, Scale, secondary, Seidman, situation, spinal, stimulating, summarize, superoxide, surface, Tanabe, Tariq, Teva, thin, tolerability, toxicology, trend, twelve, UCB, ulcer, untreated, unwilling, upper, vessel, vital, vitamin, weighted, weighting, Wyeth
Filing tables
Filing exhibits
- 10-K Annual report
- 10.24 Clinical Services Agreement with Oncotherapeutics
- 10.25 Daniel Levitt Employment Agreement
- 10.26 Scott Geyer Employment Agreement
- 10.27 Benjamin Levin Employment Agreement
- 10.28 Scott Wieland Employment Agreement
- 10.29 John Caloz Employment Agreement
- 23.1 Consent of Bdo USA, LLP
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32.1 EX-32.1
- 32.2 EX-32.2
Related press release
LADX similar filings
Filing view
External links